Le Leu Richard K, Brown Ian L, Hu Ying, Esterman Adrian, Young Graeme P
Department of Medicine, Flinders University, Bedford Park, Australia.
Cancer Biol Ther. 2007 Oct;6(10):1621-6. doi: 10.4161/cbt.6.10.4764. Epub 2007 Jul 19.
Resistant starch is a complex carbohydrate that reaches the colon where it can be fermented by the colonic microflora resulting in production of short chain fatty acids (SCFA), in particular butyrate. RS effects on colorectal tumourigenesis are contrasting and protection remains controversial. Butyrate has an important role as the preferred metabolic fuel and regulator of colonocyte proliferation, differentiation and apoptosis and may play a role in cancer prevention. Thus variation in butyrate production from different substrates might explain the variation in effect of RS. This study evaluated the hypothesis that feeding dietary resistant starch (as high amylose maize starch) would protect against azoxymethane (AOM)-colon carcinogenesis and favourably influence the colonic luminal environment. Male Sprague-Dawley rats (n = 90) were provided one of three diets: Control (without added dietary fibre or RS), 10% HAS (contained 100 g/kg raw high amylose maize starch) or 20% HAS (contained 200 g/kg high amylose maize starch). Rats were fed their experimental diets for four weeks after which they were injected with AOM (15 mg/kg) during the fifth and six week. Colons were resected (25 weeks post second injection) for evaluation of tumour formation, apoptosis, proliferating cell nuclear antigen (PCNA) labelling index and short chain fatty acid levels. Feeding resistant starch significantly reduced the incidence (p < 0.01) and multiplicity (p < 0.05) of adenocarcinomas in the colon compared to the Control diet. Both doses of HAS resulted in similar protection against colon tumourigenesis. Feeding RS significantly increased total SCFA concentrations, including butyrate in the distal colon. Apoptosis (p < 0.01) was also enhanced while PCNA labelling index was reduced (p < 0.01) in the distal colon with resistant starch feeding. The protective effect of consumption of RS as dietary high-amylose cornstarch against colon cancer development appears to be related to active fermentation in the colon, particularly through production of butyrate.
抗性淀粉是一种复杂的碳水化合物,它会到达结肠,在那里可被结肠微生物群发酵,产生短链脂肪酸(SCFA),尤其是丁酸盐。抗性淀粉对结直肠癌发生的影响存在差异,其保护作用仍存在争议。丁酸盐作为结肠细胞增殖、分化和凋亡的首选代谢燃料和调节剂具有重要作用,可能在癌症预防中发挥作用。因此,不同底物产生丁酸盐的差异可能解释了抗性淀粉作用效果的差异。本研究评估了以下假设:喂食膳食抗性淀粉(如高直链玉米淀粉)可预防偶氮甲烷(AOM)诱导的结肠癌发生,并对结肠腔内环境产生有利影响。将90只雄性斯普拉格-道利大鼠分为三组,分别给予三种饮食之一:对照组(不添加膳食纤维或抗性淀粉)、10%高直链淀粉组(含有100 g/kg生高直链玉米淀粉)或20%高直链淀粉组(含有200 g/kg高直链玉米淀粉)。大鼠接受实验饮食喂养四周,之后在第五周和第六周注射AOM(15 mg/kg)。在第二次注射后25周切除结肠,以评估肿瘤形成、细胞凋亡、增殖细胞核抗原(PCNA)标记指数和短链脂肪酸水平。与对照组饮食相比,喂食抗性淀粉显著降低了结肠腺癌的发生率(p < 0.01)和多发性(p < 0.05)。两种剂量的高直链淀粉对结肠癌发生的保护作用相似。喂食抗性淀粉显著增加了总短链脂肪酸浓度,包括远端结肠中的丁酸盐。喂食抗性淀粉时,远端结肠的细胞凋亡增强(p < 0.01),而PCNA标记指数降低(p < 0.01)。食用作为膳食高直链玉米淀粉的抗性淀粉对结肠癌发展的保护作用似乎与结肠中的活跃发酵有关,特别是通过丁酸盐的产生。